Cargando…
Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
BACKGROUND: The treatment of intratumoral dentritic cells (DCs) commonly fails because it cannot evoke immunity in a poor tumor microenvironment (TME). Modulated electro-hyperthermia (mEHT, trade-name: oncothermia) represents a significant technological advancement in the hyperthermia field, allowin...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608323/ https://www.ncbi.nlm.nih.gov/pubmed/26472466 http://dx.doi.org/10.1186/s12885-015-1690-2 |
_version_ | 1782395653162270720 |
---|---|
author | Tsang, Yuk-Wah Huang, Cheng-Chung Yang, Kai-Lin Chi, Mau-Shin Chiang, Hsin-Chien Wang, Yu-Shan Andocs, Gabor Szasz, Andras Li, Wen-Tyng Chi, Kwan-Hwa |
author_facet | Tsang, Yuk-Wah Huang, Cheng-Chung Yang, Kai-Lin Chi, Mau-Shin Chiang, Hsin-Chien Wang, Yu-Shan Andocs, Gabor Szasz, Andras Li, Wen-Tyng Chi, Kwan-Hwa |
author_sort | Tsang, Yuk-Wah |
collection | PubMed |
description | BACKGROUND: The treatment of intratumoral dentritic cells (DCs) commonly fails because it cannot evoke immunity in a poor tumor microenvironment (TME). Modulated electro-hyperthermia (mEHT, trade-name: oncothermia) represents a significant technological advancement in the hyperthermia field, allowing the autofocusing of electromagnetic power on a cell membrane to generate massive apoptosis. This approach turns local immunogenic cancer cell death (apoptosis) into a systemic anti-tumor immune response and may be implemented by treatment with intratumoral DCs. METHODS: The CT26 murine colorectal cancer model was used in this investigation. The inhibition of growth of the tumor and the systemic anti-tumor immune response were measured. The tumor was heated to a core temperature of 42 °C for 30 min. The matured synergetic DCs were intratumorally injected 24 h following mEHT was applied. RESULTS: mEHT induced significant apoptosis and enhanced the release of heat shock protein70 (Hsp70) in CT26 tumors. Treatment with mEHT-DCs significantly inhibited CT26 tumor growth, relative to DCs alone or mEHT alone. The secondary tumor protection effect upon rechallenging was observed in mice that were treated with mEHT-DCs. Immunohistochemical staining of CD45 and F4/80 revealed that mEHT-DC treatment increased the number of leukocytes and macrophages. Most interestingly, mEHT also induced infiltrations of eosinophil, which has recently been reported to be an orchestrator of a specific T cell response. Cytotoxic T cell assay and ELISpot assay revealed a tumor-specific T cell activity. CONCLUSIONS: This study demonstrated that mEHT induces tumor cell apoptosis and enhances the release of Hsp70 from heated tumor cells, unlike conventional hyperthermia. mEHT can create a favorable tumor microenvironment for an immunological chain reaction that improves the success rate of intratumoral DC immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1690-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4608323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46083232015-10-17 Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy Tsang, Yuk-Wah Huang, Cheng-Chung Yang, Kai-Lin Chi, Mau-Shin Chiang, Hsin-Chien Wang, Yu-Shan Andocs, Gabor Szasz, Andras Li, Wen-Tyng Chi, Kwan-Hwa BMC Cancer Research Article BACKGROUND: The treatment of intratumoral dentritic cells (DCs) commonly fails because it cannot evoke immunity in a poor tumor microenvironment (TME). Modulated electro-hyperthermia (mEHT, trade-name: oncothermia) represents a significant technological advancement in the hyperthermia field, allowing the autofocusing of electromagnetic power on a cell membrane to generate massive apoptosis. This approach turns local immunogenic cancer cell death (apoptosis) into a systemic anti-tumor immune response and may be implemented by treatment with intratumoral DCs. METHODS: The CT26 murine colorectal cancer model was used in this investigation. The inhibition of growth of the tumor and the systemic anti-tumor immune response were measured. The tumor was heated to a core temperature of 42 °C for 30 min. The matured synergetic DCs were intratumorally injected 24 h following mEHT was applied. RESULTS: mEHT induced significant apoptosis and enhanced the release of heat shock protein70 (Hsp70) in CT26 tumors. Treatment with mEHT-DCs significantly inhibited CT26 tumor growth, relative to DCs alone or mEHT alone. The secondary tumor protection effect upon rechallenging was observed in mice that were treated with mEHT-DCs. Immunohistochemical staining of CD45 and F4/80 revealed that mEHT-DC treatment increased the number of leukocytes and macrophages. Most interestingly, mEHT also induced infiltrations of eosinophil, which has recently been reported to be an orchestrator of a specific T cell response. Cytotoxic T cell assay and ELISpot assay revealed a tumor-specific T cell activity. CONCLUSIONS: This study demonstrated that mEHT induces tumor cell apoptosis and enhances the release of Hsp70 from heated tumor cells, unlike conventional hyperthermia. mEHT can create a favorable tumor microenvironment for an immunological chain reaction that improves the success rate of intratumoral DC immunotherapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1690-2) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-15 /pmc/articles/PMC4608323/ /pubmed/26472466 http://dx.doi.org/10.1186/s12885-015-1690-2 Text en © Tsang et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tsang, Yuk-Wah Huang, Cheng-Chung Yang, Kai-Lin Chi, Mau-Shin Chiang, Hsin-Chien Wang, Yu-Shan Andocs, Gabor Szasz, Andras Li, Wen-Tyng Chi, Kwan-Hwa Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
title | Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
title_full | Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
title_fullStr | Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
title_full_unstemmed | Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
title_short | Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
title_sort | improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608323/ https://www.ncbi.nlm.nih.gov/pubmed/26472466 http://dx.doi.org/10.1186/s12885-015-1690-2 |
work_keys_str_mv | AT tsangyukwah improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT huangchengchung improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT yangkailin improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT chimaushin improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT chianghsinchien improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT wangyushan improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT andocsgabor improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT szaszandras improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT liwentyng improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy AT chikwanhwa improvingimmunologicaltumormicroenvironmentusingelectrohyperthermiafollowedbydendriticcellimmunotherapy |